PAI
ACAD icon

Palo Alto Investors’s Acadia Pharmaceuticals ACAD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$55.3M Sell
2,563,209
-100,716
-4% -$2.17M 11.76% 2
2025
Q1
$44.2M Sell
2,663,925
-84,674
-3% -$1.41M 8.43% 4
2024
Q4
$50.4M Buy
2,748,599
+224,643
+9% +$4.12M 7.82% 5
2024
Q3
$38.8M Buy
2,523,956
+105,115
+4% +$1.62M 5.04% 7
2024
Q2
$39.3M Buy
2,418,841
+3,898
+0.2% +$63.3K 4.55% 8
2024
Q1
$44.7M Buy
2,414,943
+5,387
+0.2% +$99.6K 5.04% 7
2023
Q4
$75.4M Buy
2,409,556
+3,763
+0.2% +$118K 6.8% 6
2023
Q3
$50.1M Hold
2,405,793
4.74% 9
2023
Q2
$57.6M Hold
2,405,793
4.65% 9
2023
Q1
$45.3M Buy
2,405,793
+29,424
+1% +$554K 3.75% 9
2022
Q4
$37.8M Buy
2,376,369
+698,173
+42% +$11.1M 3.23% 9
2022
Q3
$27.5M Hold
1,678,196
2.17% 12
2022
Q2
$23.6M Sell
1,678,196
-573,638
-25% -$8.08M 2.06% 13
2022
Q1
$54.5M Sell
2,251,834
-86,043
-4% -$2.08M 4.22% 10
2021
Q4
$54.6M Hold
2,337,877
3.49% 10
2021
Q3
$38.8M Hold
2,337,877
2.34% 12
2021
Q2
$57M Hold
2,337,877
3.14% 12
2021
Q1
$60.3M Buy
2,337,877
+36,400
+2% +$939K 3.44% 10
2020
Q4
$123M Buy
2,301,477
+469,177
+26% +$25.1M 6.45% 6
2020
Q3
$75.6M Buy
1,832,300
+267,400
+17% +$11M 4.15% 9
2020
Q2
$75.9M Sell
1,564,900
-66,624
-4% -$3.23M 4.55% 10
2020
Q1
$68.9M Sell
1,631,524
-273,850
-14% -$11.6M 5.77% 9
2019
Q4
$81.5M Sell
1,905,374
-271,303
-12% -$11.6M 4.49% 11
2019
Q3
$78.3M Sell
2,176,677
-132,126
-6% -$4.76M 5.22% 9
2019
Q2
$61.7M Buy
2,308,803
+60,400
+3% +$1.61M 3% 15
2019
Q1
$60.4M Buy
2,248,403
+222,340
+11% +$5.97M 2.52% 15
2018
Q4
$32.8M Buy
2,026,063
+341,883
+20% +$5.53M 1.74% 19
2018
Q3
$35M Buy
1,684,180
+33,400
+2% +$693K 1.41% 20
2018
Q2
$25.2M Hold
1,650,780
1.01% 22
2018
Q1
$37.1M Buy
1,650,780
+9,750
+0.6% +$219K 1.59% 19
2017
Q4
$49.4M Hold
1,641,030
2.13% 14
2017
Q3
$61.8M Buy
1,641,030
+27,700
+2% +$1.04M 2.6% 13
2017
Q2
$45M Buy
1,613,330
+22,900
+1% +$639K 2.1% 14
2017
Q1
$54.7M Buy
1,590,430
+58,400
+4% +$2.01M 2.58% 15
2016
Q4
$44.2M Buy
1,532,030
+50,100
+3% +$1.44M 2.52% 13
2016
Q3
$47.1M Buy
1,481,930
+44,200
+3% +$1.41M 2.74% 13
2016
Q2
$46.7M Buy
1,437,730
+952,630
+196% +$30.9M 3.53% 8
2016
Q1
$13.6M Buy
+485,100
New +$13.6M 1.05% 25